Sylvain Huille

Title: Sylvain Huille: Innovator in Antibody-Drug Conjugate Formulations

Introduction

Sylvain Huille is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of multiple myeloma. With a total of 3 patents, Huille's work focuses on innovative therapeutic methods that enhance patient outcomes.

Latest Patents

One of Huille's latest patents is the "CEACAM5 Antibody-Drug Conjugate Formulation." This patent outlines methods for treating multiple myeloma, specifically targeting individuals who have undergone at least two prior therapies. The methods involve administering an anti-CD38 antibody, pomalidomide, and dexamethasone to improve treatment efficacy. Additionally, the patent addresses methods for improving renal impairment in patients suffering from multiple myeloma.

Career Highlights

Throughout his career, Sylvain Huille has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Sanofi. His experience in these organizations has allowed him to develop and refine his innovative approaches to treatment.

Collaborations

Huille has collaborated with several professionals in his field, including Audrey Bonestebe and Lucie Manache-Alberici. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Sylvain Huille's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving treatment options for patients with multiple myeloma. His innovative approaches continue to pave the way for advancements in therapeutic methods.